RXST

RXST

Rxsight Inc

RxSight, Inc. develops and sells light adjustable intraocular lenses used in cataract surgery. Its RxSight system customizes visual acuity post-surgery through a light delivery device that adjusts the lens shape using ultraviolet light.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$563today

Score Overview

1 Year
Score
Net Growth-20.56%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-5.13%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.8
Net Growth3.57%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth464.69%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth3.57%
Net Trend40%
Net Income Consistency
Rev Growth464.69%
Rev Trend60%
Revenue Consistency

See the full market ranking โ†’

Rxsight Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 22M to $ 134M and net income went from -$ 48M to -$ 38M. Revenue increased in 60% of the years measured; net income in 40%.

Rxsight Inc currently holds a 5-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 7.06โ€”
1 Year2025-08-12
$ 7.35-3.95%
5 Years2021-08-12
$ 12.54-43.70%
All Time2021-07-30
$ 16.00-55.88%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 127M-$ 46M$ 208M
2025$ 134M-$ 38M$ 228M
2024$ 139M-$ 27M$ 237M
2023$ 89M-$ 48M$ 127M
2022$ 49M-$ 66M$ 105M
IPO2021$ 22M-$ 48M$ 159M

Explore beyond RXST

You're looking at Rxsight Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies